0001140361-22-014327.txt : 20220413 0001140361-22-014327.hdr.sgml : 20220413 20220413135632 ACCESSION NUMBER: 0001140361-22-014327 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20220408 FILED AS OF DATE: 20220413 DATE AS OF CHANGE: 20220413 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Pepose Jay CENTRAL INDEX KEY: 0001866191 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-34079 FILM NUMBER: 22824352 MAIL ADDRESS: STREET 1: 37000 GRAND RIVER AVE STREET 2: SUITE 120 CITY: FARMINGTON HILLS STATE: MI ZIP: 48335 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Ocuphire Pharma, Inc. CENTRAL INDEX KEY: 0001228627 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 113516358 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 37000 GRAND RIVER AVE. STREET 2: SUITE 120 CITY: FARMINGTON HILLS STATE: MI ZIP: 48335 BUSINESS PHONE: 248-681-9815 MAIL ADDRESS: STREET 1: 37000 GRAND RIVER AVE. STREET 2: SUITE 120 CITY: FARMINGTON HILLS STATE: MI ZIP: 48335 FORMER COMPANY: FORMER CONFORMED NAME: REXAHN PHARMACEUTICALS, INC. DATE OF NAME CHANGE: 20050516 FORMER COMPANY: FORMER CONFORMED NAME: CORPORATE ROAD SHOW DOT COM INC DATE OF NAME CHANGE: 20030423 4 1 form4.xml FORM 4 X0306 4 2022-04-08 0001228627 Ocuphire Pharma, Inc. OCUP 0001866191 Pepose Jay C/O OCUPHIRE PHARMA, INC. 37000 GRAND RIVER AVE, SUITE 120 FARMINGTON HILLS MI 48335 true Stock Option (right to buy) 2.9 2022-04-08 4 A 0 50000 0 A 2032-04-07 Common Stock 50000 50000 D The option will vest with respect to 12,500 shares on March 31, 2023, and then with respect to 1,041 shares on the last day of each month from April 2023 through February 2026 and with respect to 1,065 shares at the end of March 2026, subject to the Reporting Person's continuing service through each applicable vesting date. /s/ Emily J. Johns, by Power of Attorney 2022-04-13